The effect of polyphenol-rich interventions on cardiovascular risk factors in haemodialysis: A systematic review and meta-analysis

Nutrients

Volumn 9, Issue 12, 2017, Pages

  Marx, Wolfgang ^a,b   Kelly, Jaimon ^b   Marshall, Skye ^b   Nakos, Stacey ^a   Campbell, Katrina ^b   Itsiopoulos, Catherine ^a  

^a LA TROBE UNIVERSITY   (Australia)

^b BOND UNIVERSITY   (Australia)

Author keywords

Blood pressure; Cardiovascular; Cocoa; Dialysis; Inflammation; Meta analysis; Oxidative stress; Polyphenol; Pomegranate; Review; Soy; Turmeric

Indexed keywords

8 HYDROXYDEOXYGUANOSINE; ADVANCED OXIDATION PROTEIN PRODUCT; C REACTIVE PROTEIN; CATECHIN; CURCUMIN; FLAVANOL DERIVATIVE; GALLIC ACID; GLUTATHIONE; GLUTATHIONE PEROXIDASE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INTERLEUKIN 6; ISOFLAVONE; LOW DENSITY LIPOPROTEIN CHOLESTEROL; MALONALDEHYDE; MYELOPEROXIDASE; POLYPHENOL; TRIACYLGLYCEROL; TUMOR NECROSIS FACTOR; TURMERIC; BIOLOGICAL MARKER; PEROXIDASE;

ARTERIAL WALL THICKNESS; CACAO; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; DATA ANALYSIS; DATA EXTRACTION; DIASTOLIC BLOOD PRESSURE; DIET SUPPLEMENTATION; END STAGE RENAL DISEASE; GRAPE; HEMODIALYSIS; HUMAN; META ANALYSIS; ORAC ASSAY; OXIDATIVE STRESS; POMEGRANATE; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SYSTEMATIC REVIEW; SYSTOLIC BLOOD PRESSURE; TOTAL CHOLESTEROL LEVEL; ANALYSIS; BLOOD; BLOOD PRESSURE; CHEMISTRY; CHRONIC KIDNEY FAILURE; COMPLICATION; CURCUMA; DIET THERAPY; DRUG EFFECT; LYTHRACEAE; MULTIMODALITY CANCER THERAPY; PATHOPHYSIOLOGY; PROCEDURES; RISK FACTOR; SOY FOOD; VITIS;

BIOMARKERS; BLOOD PRESSURE; CARDIOVASCULAR DISEASES; COMBINED MODALITY THERAPY; CURCUMA; DIET THERAPY; HUMANS; KIDNEY FAILURE, CHRONIC; PEROXIDASE; POLYPHENOLS; PUNICACEAE; RENAL DIALYSIS; RISK FACTORS; SOY FOODS; TRIGLYCERIDES; VITIS;

EID: 85037817611     PISSN: None     EISSN: 20726643     Source Type: Journal    
DOI: 10.3390/nu9121345     Document Type: Review

References (52)

1. Couser, W.G.; Remuzzi, G.; Mendis, S.; Tonelli, M. The contribution of chronic kidney disease to the global burden of major noncommunicable diseases. Kidney Int. 2011, 80, 1258-1270.
2. De Jager, D.J.; Grootendorst, D.C.; Jager, K.J.; van Dijk, P.C.; Tomas, L.M.; Ansell, D.; Collart, F.; Finne, P.; Heaf, J.G.; De Meester, J.; et al. Cardiovascular and noncardiovascular mortality among patients starting dialysis. JAMA 2009, 302, 1782-1789.
3. Stenvinkel, P.; Carrero, J.J.; Axelsson, J.; Lindholm, B.; Heimbürger, O.; Massy, Z. Emerging biomarkers for evaluating cardiovascular risk in the chronic kidney disease patient: How do new pieces fit into the uremic puzzle? Clin. J. Am. Soc. Nephrol. 2008, 3, 505-521.
4. Stenvinkel, P.; Larsson, T.E. Chronic kidney disease: A clinical model of premature aging. Am. J. Kidney Dis. 2013, 62, 339-351.
5. Santoro, A.; Mancini, E. Cardiac effects of chronic inflammation in dialysis patients. Nephrol. Dial. Transplant. 2002, 17, 10-15.
6. Carrero, J.J.; Stenvinkel, P. Inflammation in End-Stage Renal Disease-What Have We Learned in 10 Years? Semin. Dial. 2010, 23, 498-509.
7. Morena, M.; Delbosc, S.; Dupuy, A.M.; Canaud, B.; Cristol, J.P. Overproduction of reactive oxygen species in end-stage renal disease patients: A potential component of hemodialysis-associated inflammation. Hemodial. Int. 2005, 9, 37-46.
8. Kelly, J.T.; Palmer, S.C.; Wai, S.N.; Ruospo, M.; Carrero, J.J.; Campbell, K.L.; Strippoli, G.F. Healthy Dietary Patterns and Risk of Mortality and ESRD in CKD: A Meta-Analysis of Cohort Studies. Clin. J. Am. Soc. Nephrol. 2017, 12, 272-279.
9. Luis, D.; Zlatkis, K.; Comenge, B.; Garcia, Z.; Navarro, J.F.; Lorenzo, V.; Carrero, J.J. Dietary Quality and Adherence to Dietary Recommendations in Patients Undergoing Hemodialysis. J. Ren. Nutr. 2016, 26, 190-195.
10. Kelly, J.T.; Rossi, M.; Johnson, D.W.; Campbell, K.L. Beyond Sodium, Phosphate and Potassium: Potential Dietary Interventions in Kidney Disease. Semin. Dial. 2017, 30, 197-202.
11. Chan, M.; Kelly, J.; Tapsell, L. Dietary Modeling of Foods for Advanced CKD Based on General Healthy Eating Guidelines: What Should Be on the Plate? Am. J. Kidney Dis. 2017, 69, 436-450.
12. Grassi, D.; Desideri, G.; Ferri, C. Flavonoids: Antioxidants Against Atherosclerosis. Nutrients 2010, 2, 889.
13. Wang, X.; Ouyang, Y.; Liu, J.; Zhu, M.; Zhao, G.; Bao, W.; Hu, F.B. Fruit and vegetable consumption and mortality from all causes, cardiovascular disease, and cancer: Systematic review and dose-response metaanalysis of prospective cohort studies. BMJ 2014, 349, doi: 10.1136/bmj.g4490.
14. Peterson, J.J.; Dwyer, J.T.; Jacques, P.F.; McCullough, M.L. Associations between flavonoids and cardiovascular disease incidence or mortality in European and US populations. Nutr. Rev. 2012, 70, 491-508.
15. Tresserra-Rimbau, A.; Rimm, E.B.; Medina-Remón, A.; Martínez-González, M.A.; López-Sabater, M.C.; Covas, M.I.; Corella, D.; Salas-Salvadó, J.; Gómez-Gracia, E.; Lapetra, J.; et al. Polyphenol intake and mortality risk: A re-analysis of the PREDIMED trial. BMC Med. 2014, 12, 77.
16. Tresserra-Rimbau, A.; Rimm, E.B.; Medina-Remón, A.; Martínez-González, M.A.; de la Torre, R.; Corella, D.; Salas-Salvadó, J.; Gómez-Gracia, E.; Lapetra, J.; Arós, F.; et al. Inverse association between habitual polyphenol intake and incidence of cardiovascular events in the PREDIMED study. Nutr. Metab. Cardiovasc. Dis. 2014, 24, 639-647, doi: 10.1016/j.numecd.2013.12.014.
17. Rienks, J.; Barbaresko, J.; Nöthlings, U. Association of Polyphenol Biomarkers with Cardiovascular Disease and Mortality Risk: A Systematic Review and Meta-Analysis of Observational Studies. Nutrients 2017, 9, 415.
18. Manach, C.; Scalbert, A.; Morand, C.; Rémésy, C.; Jiménez, L. Polyphenols: Food sources and bioavailability Am. J. Clin. Nutr. 2004, 79, 727-747.
19. Joseph, S.V.; Edirisinghe, I.; Burton-Freeman, B.M. Fruit polyphenols: A review of anti-inflammatory effects in humans. Crit. Rev. Food Sci. Nutr. 2016, 56, 419-444.
20. Zern, T.L.; West, K.L.; Fernandez, M.L. Grape polyphenols decrease plasma triglycerides and cholesterol accumulation in the aorta of ovariectomized guinea pigs. J. Nutr. 2003, 133, 2268-2272.
21. Diebolt, M.; Bucher, B.; Andriantsitohaina, R. Wine polyphenols decrease blood pressure, improve NO vasodilatation, and induce gene expression. Hypertension 2001, 38, 159-165.
22. Abdollahzad, H.; Eghtesadi, S.; Nourmohammadi, I.; Khadem-Ansari, M.; Nejad-Gashti, H.; Esmaillzadeh, A. Effect of vitamin C supplementation on oxidative stress and lipid profiles in hemodialysis patients. Int. J. Vitam. Nutr. Res. 2009, 79, 281-287.
23. Bhogade, R.; Suryakar, A.; Joshi, N.; Patil, R. Effect of vitamin E supplementation on oxidative stress in hemodialysis patients. Indian J. Clin. Biochem. 2008, 23, 233-237.
24. Baldi, S.; Innocenti, M.; Frascerra, S.; Nannipieri, M.; Lippi, A.; Rindi, P.; Ferrannini, E. Effects of hemodialysis and vitamin E supplementation on low-density lipoprotein oxidizability in end-stage renal failure. J. Nephrol. 2013, 26, 549-555, doi: 10.5301/jn.5000190.
25. Janiques, A.G.; Leal Vde, O.; Stockler-Pinto, M.B.; Moreira, N.X.; Mafra, D. Effects of grape powder supplementation on inflammatory and antioxidant markers in hemodialysis patients: A randomized double-blind study. J. Bras. Nefrol. 2014, 36, 496-501.
26. Shema-Didi, L.; Kristal, B.; Ore, L.; Shapiro, G.; Geron, R.; Sela, S. Pomegranate juice intake attenuates the increase in oxidative stress induced by intravenous iron during hemodialysis. Nutr. Res. 2013, 33, 442-446.
27. Pakfetrat, M.; Akmali, M.; Malekmakan, L.; Dabaghimanesh, M.; Khorsand, M. Role of turmeric in oxidative modulation in end-stage renal disease patients. Hemodial. Int. 2015, 19, 124-131, doi: 10.1111/hdi.12204.
28. Rassaf, T.; Rammos, C.; Hendgen-Cotta, U.B.; Heiss, C.; Kleophas, W.; Dellanna, F.; Floege, J.; Hetzel, G.R.; Kelm, M. Vasculoprotective Effects of Dietary Cocoa Flavanols in Patients on Hemodialysis: A Double-Blind, Randomized, Placebo-Controlled Trial. Clin. J. Am. Soc. Nephrol. 2016, 11, 108-118.
29. Liberati, A.; Altman, D.G.; Tetzlaff, J.; Mulrow, C.; Gøtzsche, P.C.; Ioannidis, J.P.A.; Clarke, M.; Devereaux, P.J.; Kleijnen, J.; Moher, D. The PRISMA Statement for Reporting Systematic Reviews and Meta-Analyses of Studies That Evaluate Health Care Interventions: Explanation and Elaboration. PLOS Med. 2009, 6, e1000100, doi: 10.1371/journal.pmed.1000100.
30. Perez-Jimenez, J.; Neveu, V.; Vos, F.; Scalbert, A. Identification of the 100 richest dietary sources of polyphenols: An application of the Phenol-Explorer database. Eur. J. Clin. Nutr. 2010, 64, S112-S120.
31. Rothwell, J.A.; Perez-Jimenez, J.; Neveu, V.; Medina-Remón, A.; M’Hiri, N.; García-Lobato, P.; Manach, C.; Knox, C.; Eisner, R.; Wishart, D.S.; et al. Phenol-Explorer 3.0: A major update of the Phenol-Explorer database to incorporate data on the effects of food processing on polyphenol content Database 2013, 2013, doi: 10.1093/database/bat070.
32. Higgins, J.P.T.; Green, S. Cochrane Handbook for Systematic Reviews of Interventions; Wiley Online Library: Hoboken, NJ, USA, 2008; Volume 5.
33. Guyatt, G.H.; Oxman, A.D.; Schünemann, H.J.; Tugwell, P.; Knottnerus, A. GRADE guidelines: A new series of articles in the Journal of Clinical Epidemiology J. Clin. Epidemiol. 2011, 64, 380-382.
34. Handbook for Grading the Quality of Evidence and the Strength of Recommendations Using the GRADE Approach. Updated October 2013. Available online: http://gdt.guidelinedevelopment.org (accessed on 12 April 2017).
35. DerSimonian, R.; Laird, N. Meta-analysis in clinical trials Controll. Clin. Trials 1986, 7, 177-188.
36. Shema-Didi, L.; Kristal, B.; Sela, S.; Geron, R.; Ore, L. Does Pomegranate intake attenuate cardiovascular risk factors in hemodialysis patients? Nutr. J. 2014, 13, 18.
37. Shema-Didi, L.; Sela, S.; Ore, L.; Shapiro, G.; Geron, R.; Moshe, G.; Kristal, B. One year of pomegranate juice intake decreases oxidative stress, inflammation, and incidence of infections in hemodialysis patients: A randomized placebo-controlled trial. Free Radic. Biol. Med. 2012, 53, 297-304.
38. Pakfetrat, M.; Basiri, F.; Malekmakan, L.; Roozbeh, J. Effects of turmeric on uremic pruritus in end stage renal disease patients: A double-blind randomized clinical trial. J. Nephrol. 2014, 27, 203-207.
39. Hsu, S.P.; Wu, M.S.; Yang, C.C.; Huang, K.C.; Liou, S.Y.; Hsu, S.M.; Chien, C.T. Chronic green tea extract supplementation reduces hemodialysis-enhanced production of hydrogen peroxide and hypochlorous acid, atherosclerotic factors, and proinflammatory cytokines. Am. J. Clin. Nutr. 2007, 86, 1539-1547.
40. Fanti, P.; Asmis, R.; Stephenson, T.J.; Sawaya, B.P.; Franke, A.A. Positive effect of dietary soy in ESRD patients with systemic inflammation-Correlation between blood levels of the soy isoflavones and the acute-phase reactants. Nephrol. Dial. Transplant. 2006, 21, 2239-2246, doi: 10.1093/ndt/gfl169.
41. Chen, S.; Chen, J.; Yang, C.; Peng, S.; Ferng, S. Effect of soya protein on serum lipid profile and lipoprotein concentrations in patients undergoing hypercholesterolaemic haemodialysis. Br. J. Nutr. 2006, 95, 366-371.
42. Chen, S.; Ferng, S.; Yang, C.; Peng, S.; Lee, H.; Chen, J. Variable effects of soy protein on plasma lipids in hyperlipidemic and normolipidemic hemodialysis patients. Am. J. Kidney Dis. 2005, 46, 1099-1106.
43. Siefker, K.; DiSilvestro, R.A. Safety and antioxidant effects of a modest soy protein intervention in hemodialysis patients. J. Med. Food 2006, 9, 368-372.
44. Wu, P.T.; Fitschen, P.J.; Kistler, B.M.; Jeong, J.H.; Chung, H.R.; Aviram, M.; Phillips, S.A.; Fernhall, B.; Wilund, K.R. Effects of Pomegranate Extract Supplementation on Cardiovascular Risk Factors and Physical Function in Hemodialysis Patients. J. Med. Food 2015, 18, 941-949.
45. Walle, T.; Hsieh, F.; DeLegge, M.H.; Oatis, J.E., Jr.; Walle, U.K. High absorption but very low bioavailability of oral resveratrol in humans. Drug Metab. Dispos. 2004, 32, 1377-1382, doi: 10.1124/dmd.104.000885.
46. Anand, P.; Kunnumakkara, A.B.; Newman, R.A.; Aggarwal, B.B. Bioavailability of curcumin: Problems and promises. Mol. Pharm. 2007, 4, 807-818, doi: 10.1021/mp700113r.
47. Johnson, J.J.; Nihal, M.; Siddiqui, I.A.; Scarlett, C.O.; Bailey, H.H.; Mukhtar, H.; Ahmad, N. Enhancing the bioavailability of resveratrol by combining it with piperine. Mol. Nutr. Food Res. 2011, 55, 1169-1176, doi: 10.1002/mnfr.201100117.
48. Manach, C.; Milenkovic, D.; Van de Wiele, T.; Rodriguez-Mateos, A.; de Roos, B.; Garcia-Conesa, M.T.; Landberg, R.; Gibney, E.R.; Heinonen, M.; Tomás-Barberán, F.; et al. Addressing the inter-individual variation in response to consumption of plant food bioactives: Towards a better understanding of their role in healthy aging and cardiometabolic risk reduction. Mol. Nutr. Res. 2017, 61, doi: 10.1002/mnfr.201600557.
49. Setchell, K.D.R.; Clerici, C. Equol: History, Chemistry, and Formation J. Nutr. 2010, 140, 1355S-1362S, doi: 10.3945/jn.109.119776.
50. Marín, L.; Miguélez, E.M.; Villar, C.J.; Lombó, F. Bioavailability of Dietary Polyphenols and Gut Microbiota Metabolism: Antimicrobial Properties. BioMed Res. Int. 2015, 2015, 18, doi: 10.1155/2015/905215.
51. Vaziri, N.D.; Wong, J.; Pahl, M.; Piceno, Y.M.; Yuan, J.; DeSantis, T.Z.; Ni, Z.; Nguyen, T.H.; Andersen, G.L. Chronic kidney disease alters intestinal microbial flora. Kidney Int. 2013, 83, 308-315, doi: 10.1038/ki.2012.345.
52. Ramezani, A.; Massy, Z.A.; Meijers, B.; Evenepoel, P.; Vanholder, R.; Raj, D.S. Role of the Gut Microbiome in Uremia: A Potential Therapeutic Target. Am. J. Kidney Dis. 2016, 67, 483-498, doi: 10.1053/j.ajkd.2015.09.027.